Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
457.30B | 467.78B | 507.88B | 452.12B | 359.89B | 362.88B | Gross Profit |
105.12B | 145.69B | 193.66B | 162.32B | 117.64B | 111.76B | EBIT |
-8.40B | 43.33B | 92.32B | 71.48B | 38.49B | 29.49B | EBITDA |
79.51B | 144.19B | 166.08B | 126.30B | 81.08B | 82.64B | Net Income Common Stockholders |
9.07B | 53.97B | 80.38B | 66.83B | 37.00B | 25.63B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
275.74B | 244.57B | 329.25B | 342.40B | 319.43B | 315.72B | Total Assets |
1.52T | 1.48T | 1.12T | 1.03T | 926.24B | 848.87B | Total Debt |
400.00B | 340.14B | 40.34B | 40.54B | 40.73B | 40.94B | Net Debt |
132.26B | 102.20B | -250.82B | -252.61B | -220.56B | -257.36B | Total Liabilities |
552.22B | 513.17B | 207.82B | 188.78B | 156.75B | 133.40B | Stockholders Equity |
964.48B | 967.47B | 914.91B | 839.82B | 768.97B | 714.99B |
Cash Flow | Free Cash Flow | ||||
-36.59B | -83.42B | -2.14B | 25.60B | 13.60B | 37.25B | Operating Cash Flow |
68.48B | 82.86B | 98.63B | 92.18B | 45.98B | 79.13B | Investing Cash Flow |
-88.80B | -431.95B | -88.74B | -55.44B | -40.84B | -8.68B | Financing Cash Flow |
39.40B | 265.06B | -22.15B | -16.23B | -24.84B | -17.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
62 Neutral | $11.72B | 10.43 | -7.10% | 2.91% | 7.41% | -7.94% | |
54 Neutral | $653.20B | 60.02 | -5.34% | 3.32% | -4.13% | -193.68% | |
$7.06B | 10.87 | 24.78% | 2.79% | ― | ― | ||
$9.17B | 20.08 | 44.53% | 1.72% | ― | ― | ||
77 Outperform | ¥712.92B | 19.37 | 1.24% | 32.13% | 60.02% | ||
64 Neutral | ¥192.52B | 3.80 | 0.38% | -48.30% | ― | ||
60 Neutral | ¥795.68B | 44.60 | 0.84% | 2.41% | -3.95% |